Abstract
Primary percutaneous coronary intervention (PPCI) is a swift and effective method to ensure reperfusion of the occluded coronary artery in patients with STEMI. Compared with systemic fibrinolysis, the obvious advantage is the avoidance of side effects related to fibrinolytic therapy such as bleeding, but rapid clinical assessment (including urgent bedside echocardiography) and diagnostic coronary angiography are also advantageous in the 15–20% of field-triaged patients with diagnoses other than STEMI. The initial trials documenting a mortality benefit from PPCI compared with fibrinolysis were performed prior to the era of prehospital diagnosis of STEMI. Time from symptom onset to reperfusion (either fibrinolysis or PPCI) is important with regard to mortality and morbidity; healthcare systems have thus evolved to provide the earliest possible initiation of reperfusion therapy. When initiated as part of coordinated systems, it is accepted that PPCI is superior to fibrinolysis. However, some patients are not offered reperfusion by PPCI either because of long transportation times, a lack of suitable PPCI centers, or because the healthcare system has failed to establish a successful prehospital diagnostic program with field triage of patients directly to PCI centers. Previous focus on door-to-balloon (DTB) times has been important to further streamline in-hospital care, but before the patient even reaches the hospital several factors should be in focus in order to reduce delays. Door-to-balloon time alone is a poor parameter to evaluate the efficacy of a healthcare system offering PPCI.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ACT:
-
Activated clotting time
- AHA:
-
American Heart Association
- CT:
-
Computed tomography
- ESC:
-
European Society of Cardiology
- FFR:
-
Fractional flow reserve
- LAD:
-
Left anterior descending coronary artery
- LCX:
-
Left circumflex artery
- PET:
-
Positron emission tomography
- PPCI:
-
Primary percutaneous coronary intervention
- RCA:
-
Right coronary artery
- RCT:
-
Randomized controlled trial
- STEMI:
-
ST-elevation myocardial infarction
References
Bonnefoy E, Lapostolle F, Leizorovicz A, et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet. 2002;360:825–9.
Armstrong PW, Gershlick AH, Goldstein P, et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med. 2013;368:1379–87.
Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet. 2006;367:569–78.
Ellis SG, Tendera M, de Belder MA, et al. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med. 2008;358:2205–17.
Svilaas T, Vlaar PJ, van der Horst IC, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med. 2008;358:557–67.
Fröbert O, Lagerqvist B, Olivecrona GK, et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013;369:1587–97.
Jolly SS, Cairns JA, Yusuf S, et al. Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med. 2015;372:1389–98.
Wald DS, Morris JK, Wald NJ, et al. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med. 2013;369:1115–23.
Gershlick AH, Khan JN, Kelly DJ, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol. 2015;65:963–72.
Engstrøm T, Kelbæk H, Helqvist S, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial. Lancet. 2015;386:665–71.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Holmvang, L., Joshi, F.R. (2018). Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction. In: Myat, A., Clarke, S., Curzen, N., Windecker, S., Gurbel, P.A. (eds) The Interventional Cardiology Training Manual. Springer, Cham. https://doi.org/10.1007/978-3-319-71635-0_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-71635-0_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-71633-6
Online ISBN: 978-3-319-71635-0
eBook Packages: MedicineMedicine (R0)